Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Can RA patients taper MTX from targeted therapy?

Can RA patients taper MTX from targeted therapy?

18 Jan 2023

A recent study has found that tapering methotrexate (MTX) from targeted therapy in patients with controlled rheumatoid arthritis (RA) is feasible, but this may result in a 10-percent decrease in the ability to sustain remission for up to 18 months.

18 Jan 2023